The Innovat-EV project

Innovat-EV project aims to build an innovative high-sensitivity analytical platform facilitating the development and validation of extracellular vesicle cancer diagnostic assays. In collaboration with Dispertech and Erasmus MC, the project will combine advanced single-particle analysis technologies with optimized reference materials to enable more accurate and reproducible detection of EV-based biomarkers. This enhanced analytical capability is expected to support earlier and more reliable cancer diagnosis, ultimately accelerating the translation of EV diagnostics into clinical applications.

HansaBioMed Life Sciences takes the lead in developing reference materials for advanced single-particle analyses.

HansaBioMed Life Sciences, Dispertech, Erasmus Medical Center Rotterdam